NFSG
RMD icon

Newbridge Financial Services Group’s ResMed RMD Stock Holding History

Newbridge Financial Services Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-73
Closed -$10.9K – 1300
2023
Q3 		$10.9K Sell
73
-23
-24% -$4.16K 0.01% 803
2023
Q2 		$20.9K Buy
96
+1
+1% +$223 0.01% 686
2023
Q1 		$20.9K Hold
95
– – 0.01% 702
2022
Q4 		$19.8K Hold
95
– – 0.01% 721
2022
Q3 		$21K Hold
95
– – 0.01% 682
2022
Q2 		$20K Hold
95
– – 0.01% 658
2022
Q1 		$23K Buy
95
+1
+1% +$242 0.01% 694
2021
Q4 		$25K Hold
94
– – 0.01% 659
2021
Q3 		$25K Sell
94
-1
-1% -$273 0.02% 599
2021
Q2 		$23K Hold
95
– – 0.01% 740
2021
Q1 		$18K Buy
+95
New +$19.1K 0.01% 721

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Newbridge Financial Services Group's RMD Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of ResMed (RMD) in Q4 2023, closing a stake of 73 shares — an estimated $10.9K sold.

Newbridge Financial Services Group first reported a position in RMD in Q1 2021 and held it in 11 quarters. The position peaked at $25K in Q4 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 73 ResMed shares in Q4 2023, an estimated $10.9K.
  • Newbridge Financial Services Group first reported a position in ResMed in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's ResMed position peaked at $25K in Q4 2021.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.